Also, the delivery of oncolytic adenoviruses targeting TGF-β signalling resulted in less tumour burden, osteoclasts and trabecular and cortical destruction, thus representing a possible treatment for prostate cancer bone metastasis 159. The gene discussed is TGFB1; the disease is prostate cancer.